• Sunday, October 02, 2022


Malaria vaccine wears off

Setback to experimental vaccine

By: Eastern Eye Staff

AN EXPERIMENTAL vaccine against malaria known as Mosquirix – or RTS,S – weakens over time and is only four per cent effective over a seven-year span, researchers said last Wednesday (29). The findings, published in the New England Journal of Medicine, are based on a phase II clinical trial with over 400 young children in Kenya. There is currently no vaccine against malaria on the world market and Mosquirix – developed by the British pharmaceutical giant Glaxo Smith-Kline – is the experimental vaccine in the most advanced stage of development. It has also been tested in a vast clinical trial…

You do not have access to this content. You need to subscribe.

Eastern Eye

Related Stories

Eastern Eye


Mrunal Thakur on Dhamaka, experience of working with Kartik Aaryan,…
Nushrratt Bharuccha on Chhorii, pressure of comparison with Lapachhapi, upcoming…
Abhimanyu Dassani on Meenakshi Sundareshwar, how his mom Bhagyashree reacted…